$3.48
+
$0.29 (9.09%)
End-of-day quote: 05/16/2024
NasdaqGM:CVAC
CureVac N.V. Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $597.15 | $591.94 | 0.00% | 1 | $227.94B |
| DHR | Danaher | NYSE | Outperform | $264.84 | $260.33 | 0.00% | 4 | $196.16B |
| PFE | Pfizer | NYSE | Outperform | $28.92 | $32.87 | 0.00% | 6 | $163.88B |
| SAN | Sanofi | ENXTPA | Outperform | 90.24€ | 102.80€ | 0.00% | 9 | 112.81€B |
| GSK | GSK | LSE | Outperform | £17.84 | £17.30 | 0.00% | 12 | £72.73B |
| MRNA | Moderna | NasdaqGS | Outperform | $132.68 | $135.42 | 0.00% | 1 | $50.85B |
| BNTX | BioNTech | NasdaqGS | Outperform | $92.98 | $123.75 | 0.00% | 3 | $22.22B |
| 1548 | Genscript Biotech | SEHK | Buy | HK$12.46 | HK$3.96 | 0.00% | 0 | HK$26.72B |
| TWST | Twist Bioscience | NasdaqGS | Outperform | $46.50 | $34.00 | 0.00% | 2 | $2.40B |
